Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105875071 | 10587507 | 1 | I | 20140920 | 20141103 | 20141117 | 20141117 | EXP | SE-MPA-2014-006165 | SE-NOVOPROD-428717 | NOVO NORDISK | 65.00 | YR | A | M | Y | 0.00000 | 20141117 | N | MD | SE | SE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105875071 | 10587507 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | SUBCUTANEOUS | 1.2 MG, QD | U | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD | |||||
105875071 | 10587507 | 2 | C | NovoMix 30 FlexPen | INSULIN ASPART | 1 | D | 0 | SUSPENSION FOR INJECTION | ||||||||||
105875071 | 10587507 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG TABLET | D | 0 | 500 | MG | QD | |||||||
105875071 | 10587507 | 4 | C | TROMBYL | ASPIRIN | 1 | 75 MG TABLET | D | 0 | 75 | MG | QD | |||||||
105875071 | 10587507 | 5 | C | AMLODIPIN /00972401/ | AMLODIPINE BESYLATE | 1 | 5 MG TABLET | D | 0 | 5 | MG | QD | |||||||
105875071 | 10587507 | 6 | C | LOSARTAN | LOSARTAN | 1 | 50 MG, QD | D | 0 | 50 | MG | QD | |||||||
105875071 | 10587507 | 7 | C | SIMVASTATIN SANDOZ | SIMVASTATIN | 1 | 10 MG TABLET | D | 0 | 10 | MG | QD | |||||||
105875071 | 10587507 | 8 | C | FENURIL | 2 | D | 0 | ||||||||||||
105875071 | 10587507 | 9 | C | PREDNISOLON PFIZER | PREDNISOLONE | 1 | 10 MG TABLET | D | 0 | 10 | MG | QD | |||||||
105875071 | 10587507 | 10 | C | ALLOPURINOL NYCOMED | 2 | 100 MG TABLET | D | 0 | 100 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105875071 | 10587507 | 1 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105875071 | 10587507 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105875071 | 10587507 | Acute kidney injury | |
105875071 | 10587507 | Appetite disorder | |
105875071 | 10587507 | Asthenia | |
105875071 | 10587507 | Dehydration | |
105875071 | 10587507 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
105875071 | 10587507 | 1 | 20140903 | 20141010 | 0 |